Roberta Benfante
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
CRISPR/Cas9-mediated PHOX2B functional knock-out in IMR32 neuroblastoma cells impairs neuronal excitability through dysregulation of ion channels genes.
Journal: Frontiers in physiology
Published: March 31, 2026
Regulation of PHOX2B gene expression by the long non-coding natural antisense RNA PHOX2B-AS1.
Journal: The FEBS journal
Published: May 28, 2025
Structural characterization of PHOX2B and its DNA interaction shed light on the molecular basis of the +7Ala variant pathogenicity in CCHS.
Journal: Chemical science
Published: November 30, 2023
Unanswered questions in the regulation and function of the duplicated α7 nicotinic receptor gene CHRFAM7A.
Journal: Pharmacological research
Published: March 17, 2023
Special Issue: Cholinergic Control of Inflammation.
Journal: International journal of molecular sciences
Published: July 10, 2022
Generation of two hiPSC lines (UMILi027-A and UMILi028-A) from early and late-onset Congenital Central hypoventilation Syndrome (CCHS) patients carrying a polyalanine expansion mutation in the PHOX2B gene.
Journal: Stem cell research
Published: March 19, 2022
Etonogestrel Administration Reduces the Expression of PHOX2B and Its Target Genes in the Solitary Tract Nucleus.
Journal: International journal of molecular sciences
Published: March 11, 2022
The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders.
Journal: International journal of molecular sciences
Published: January 24, 2022
Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.
Journal: Pharmacological research
Published: August 05, 2021
Research Advances on Therapeutic Approaches to Congenital Central Hypoventilation Syndrome (CCHS).
Journal: Frontiers in neuroscience
Published: October 09, 2020
Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors.
Journal: Pharmacological research
Published: September 26, 2020
Last Updated: 09/26/2026